BioDelivery Sciences Hosts Live Webcast on FDA Approval of ONSOLIS (Business Wire) RALEIGH, N.C.----BioDelivery Sciences International, Inc. will be hosting a live webcast today, Friday, July 17, 2009, at 10:00AM EST, regarding yesterdays approval from the U.S. Food and Drug Administration to market ONSOLIS⢠, formerly referred to as BEMA⢠Fentanyl, for the management of breakthrough pain in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. |